Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia ; volume:16 ; number:1 ; day:27 ; month:2 ; year:2023 ; pages:1-6 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (27.2.2023), 1-6, 12.2023
- Urheber
-
Mo, Jianshan
Deng, Lin
Peng, Keren
Ouyang, Shumin
Ding, Wen
Lou, Linlin
Lin, Ziyou
Zhu, Jianzheng
Li, Jingwei
Zhang, Qiyi
Wang, Pengyan
Wen, Yuanzhen
Chen, Xiaobing
Yue, Peibin
Lu, Jin-Jian
Zhu, Kai
Zheng, Yongjiang
Wang, Yuanxiang
Zhang, Xiaolei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01410-y
- URN
-
urn:nbn:de:101:1-2023101521172478271852
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mo, Jianshan
- Deng, Lin
- Peng, Keren
- Ouyang, Shumin
- Ding, Wen
- Lou, Linlin
- Lin, Ziyou
- Zhu, Jianzheng
- Li, Jingwei
- Zhang, Qiyi
- Wang, Pengyan
- Wen, Yuanzhen
- Chen, Xiaobing
- Yue, Peibin
- Lu, Jin-Jian
- Zhu, Kai
- Zheng, Yongjiang
- Wang, Yuanxiang
- Zhang, Xiaolei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
RBFOX2 recognizes N 6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Stat3 Prevents Mitophagy and Lysosomal Membrane Permeabilization in Intestinal Epithelial Cells to Suppress Adaptive Immunity during Tumorigenesis
Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia
STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
RBFOX2 recognizes N 6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Stat3 Prevents Mitophagy and Lysosomal Membrane Permeabilization in Intestinal Epithelial Cells to Suppress Adaptive Immunity during Tumorigenesis
Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia
STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
RBFOX2 recognizes N 6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Stat3 Prevents Mitophagy and Lysosomal Membrane Permeabilization in Intestinal Epithelial Cells to Suppress Adaptive Immunity during Tumorigenesis
Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
STAT3-mediated therapy resistance of malignant stem cells in chronic myeloid leukemia (CML)
Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia